摘要
目的分析门冬氨酸钾镁治疗急性心肌梗死心律失常的临床疗效。方法选择2017年10月-2018年10月收治的急性心肌梗死心律失常患者70例作为研究对象。依据随机原则,将其划分位两组,设为研究组(35例,门冬氨酸钾镁治疗)与参照组(35例,常规治疗),对比两组患者的治疗总有效率、血清钾、血清镁含量。结果研究组患者的治疗总有效率(97.14%)低于参照组(80.00%),差异具有统计学意义(P<0.05);研究组血清钾、血清镁的含量高于参照组,差异具有统计学意义(P<0.05)。研究组心律失常发生率(5.71%)低于参照组(22.86%),差异具有统计学意义(P<0.05)。结论急性心肌梗死心律失常应用门冬氨酸钾镁治疗可获取显著的效果,同时可升高血清钾、血清镁。
Objective To analyze the clinical efficacy of potassium magnesium aspartate in the treatment of arrhythmia in acute myocardial infarction.Methods 70 patients with arrhythmia in acute myocardial infarction admitted from October 2017 to October 2018 were selected as the study subjects.According to the principle of randomization,they were divided into two groups:the study group(35 cases treated with potassium and magnesium aspartate)and the control group(35 cases treated with conventional therapy).The total effective rate,serum potassium and serum magnesium levels of the two groups were compared.Results The total effective rate of the study group(97.14%)was lower than that of the control group(80.00%),the difference was statistically significant(P<0.05).The contents of serum potassium and magnesium in the study group were higher than those in the control group,with statistical significance(P<0.05).The incidence of arrhythmia in the study group(5.71%)was lower than that in the control group(22.86%).The difference was statistically significant(P<0.05).Conclusion Arrhythmia in acute myocardial infarction can achieve significant effects in the treatment of potassium magnesium aspartate,and can increase serum potassium and serum magnesium.
作者
周冰
ZHOU Bing(Department of Cardiology,Shengli Hospital of Shengli Petroleum Administration Co.,Ltd.,Sinopec Group,Dongying Shandong 257000,China)
出处
《中国继续医学教育》
2019年第20期141-143,共3页
China Continuing Medical Education
关键词
门冬氨酸钾镁
急性心肌梗死
心律失常
总有效率
不良反应
价值
potassium magnesium aspartate
acute myocardial infarction
arrhythmia
total effective rate
adverse reactions
value
